Related Experiment Video
Updated: Jul 5, 2026
07:05
Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Published on: November 9, 2016
Advanced botulinum toxin techniques against wrinkles in the upper face
Giovanni Salti1, Ilaria Ghersetich
1Florence Surgical Center, Florence, Italy.
Clinics in Dermatology
|May 13, 2008
Summary
Botulinum toxin type A is a safe and effective treatment for facial rejuvenation. Individualized treatment planning, considering anatomy and patient goals, is crucial for optimal aesthetic outcomes.
Area of Science:
- Aesthetic medicine
- Dermatology
- Plastic surgery
Background:
- Botulinum toxin type A is widely used for facial rejuvenation.
- Extensive clinical experience confirms its long-term efficacy and safety.
- Factors like injection technique, dosage, and patient characteristics can impact results.
Purpose of the Study:
- To provide recommendations for the optimal use of botulinum toxin type A in aesthetic medicine.
- To emphasize the importance of individualized treatment planning for facial enhancement.
- To highlight the role of anatomical and physiological understanding in achieving successful outcomes.
Main Methods:
- Review of clinical and study experience with botulinum toxin type A.
- Analysis of factors influencing treatment outcomes.
- Development of general principles and specific use recommendations.
Main Results:
- Botulinum toxin type A demonstrates long-term effectiveness and safety for facial rejuvenation.
- Variability in technique, dosage, dilution, and storage can affect results.
- Individualized aesthetic planning, based on anatomy and patient expectations, is key.
Conclusions:
- Personalized treatment strategies are essential for maximizing the benefits of botulinum toxin type A.
- A thorough understanding of facial anatomy and physiology is fundamental for practitioners.
- Achieving optimal aesthetic results requires tailoring the treatment to individual patient needs and goals.
Related Concept Videos
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
01:22Botulism
Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
01:14Muscles for Facial Expressions
The craniofacial muscles are a collection of approximately 20 thin skeletal muscles situated beneath the skin of the face and scalp. These muscles, primarily responsible for the vast array of human facial expressions, originate from the bones or fibrous structures of the skull and extend outwards to connect with the skin. While most skeletal muscles in the body are enveloped in thick fascia, facial muscles generally have a more delicate fascial covering, with the buccinator muscle being a...
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
01:24Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...